Neurocrine BiosciencesNBIX
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 700 institutions reported holding Neurocrine Biosciences Inc. (NBIX) in their 13F filings, down 33 from Q4 2025. 68 opened new positions and 106 sold out. The largest holders were BlackRock, Inc. ($1.8B), Dodge & Cox ($719.4M) and JPMorgan Chase & Co. ($700.5M). 9 famous investors held it, including Jim Simons / Peter Brown (0.5% of Renaissance Technologies's portfolio), Cliff Asness (0.3% of AQR Capital Management's portfolio) and Joel Greenblatt (0.1% of Gotham Asset Management's portfolio).
- Company
- Neurocrine Biosciences Inc.
- CUSIP
- 64125C109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 68 | $281.5M |
| Exits | 106 | $440.1M |
All 13F filers, Q4 2025 → Q1 2026: 13,910,095 shares bought and 11,451,743 shares sold, net +2,458,352 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 700 holders
| BlackRock, Inc. | 0.03% | Add +4.3% | 13,385,607 | $1.8B |
| Dodge & Cox | 0.40% | Reduce -0.8% | 5,461,037 | $719.4M |
| JPMorgan Chase & Co. | 0.05% | Add +4.7% | 5,442,067 | $700.5M |
| AQR Capital Management | 0.30% | Add +51.0% | 4,938,967 | $650.7M |
| Vanguard Portfolio Management LLC | 0.03% | — | 4,726,344 | $622.6M |
| Vanguard Capital Management LLC | 0.01% | — | 4,511,904 | $594.4M |
| State Street Corp. | 0.02% | Add +2.6% | 4,354,526 | $573.7M |
| Two Sigma Investments, LP | 0.35% | Add +210.8% | 3,060,570 | $403.2M |
| Renaissance Technologies | 0.50% | Add +8.0% | 2,418,897 | $318.7M |
| Geode Capital Management, LLC | 0.02% | Add +3.8% | 2,136,672 | $280.8M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.23% | Add +7.0% | 1,493,813 | $196.8M |
| Wellington Management Group LLP | 0.03% | Reduce -20.4% | 1,389,539 | $183.1M |
| Vestal Point Capital, LP | 4.60% | New | 1,250,000 | $164.7M |
| Millennium Management | 0.13% | Add +181.7% | 1,247,447 | $164.3M |
| Northern Trust Corp. | 0.02% | Add +1.8% | 1,242,830 | $163.7M |
| UBS Group AG | 0.03% | Add +24.1% | 1,221,036 | $160.9M |
| Morgan Stanley | 0.01% | Add +0.8% | 1,219,196 | $160.6M |
| RTW Investments, LP | 1.39% | No change | 1,062,072 | $139.9M |
| First Trust Advisors LP | 0.09% | Add +97.0% | 959,217 | $126.4M |
| Charles Schwab Investment Management Inc. | 0.02% | Add +6.1% | 902,788 | $118.9M |
| Ieq Capital, LLC | 0.47% | Add +2.8% | 765,982 | $100.9M |
| Victory Capital Management Inc. | 0.06% | Add +487.4% | 731,609 | $96.4M |
| Armistice Capital, LLC | 3.15% | Reduce -11.7% | 724,000 | $95.4M |
| Dimensional Fund Advisors LP | 0.02% | Reduce -0.7% | 711,762 | $93.8M |
| Bank of New York Mellon Corp | 0.02% | Reduce -4.9% | 702,492 | $92.5M |
| Braidwell LP | 3.27% | Reduce -13.2% | 652,121 | $85.9M |
| Fiera Capital Corp | 0.29% | Add +2.2% | 651,255 | $85.8M |
| Vanguard Fiduciary Trust Co. | 0.02% | — | 634,340 | $83.6M |
| Franklin Resources Inc. | 0.02% | Add +14.7% | 611,264 | $80.5M |
| Deerfield Management Company, L.P. | 1.12% | Reduce -48.5% | 610,000 | $80.4M |
| Pictet Asset Management Holding SA | 0.08% | Reduce -22.4% | 602,643 | $78.9M |
| Raymond James Financial Inc. | 0.02% | Reduce -4.7% | 601,487 | $78.3M |
| GW&K Investment Management, LLC | 0.69% | Add +3.0% | 593,725 | $78.2M |
| Bank of America Corp. | 0.01% | Add +10.6% | 583,827 | $76.9M |
| Swedbank AB | 0.08% | Reduce -0.8% | 579,429 | $76.3M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.02% | Reduce -20.9% | 571,719 | $75.3M |
| Alliancebernstein L.P. | 0.02% | Reduce -5.8% | 523,533 | $74.3M |
| Jacobs Levy Equity Management, Inc. | 0.29% | Add +1389.6% | 520,269 | $68.5M |
| Ameriprise Financial Inc. | 0.02% | Reduce -12.6% | 512,033 | $67.5M |
| Marshall Wace, LLP | 0.07% | Add +45.9% | 508,977 | $67.1M |
| Primecap Management Co. | 0.05% | Reduce -2.3% | 496,340 | $65.4M |
| Squarepoint Ops LLC | 0.14% | Add +132.7% | 487,953 | $64.3M |
| Janus Henderson Group PLC | 0.03% | Add +1.7% | 466,977 | $61.5M |
| Nuveen, LLC | 0.02% | Add +54.5% | 443,052 | $58.4M |
| Man Group plc | 0.12% | Add +79.9% | 415,909 | $54.8M |
| Hood River Capital Management LLC | 0.53% | Add +3.9% | 404,393 | $53.3M |
| Hudson Bay Capital Management LP | 0.35% | Add +29.8% | 395,850 | $52.1M |
| Legal & General Group Plc | 0.01% | Add +15.1% | 380,589 | $50.1M |
| Deutsche Bank AG | 0.02% | Reduce -0.7% | 365,345 | $48.1M |
| Gotham Asset Management | 0.15% | Add +113.6% | 360,136 | $47.4M |
| Invesco Ltd. | 0.00% | Add +3.7% | 356,009 | $46.9M |
| Acadian Asset Management LLC | 0.07% | Add +40.8% | 350,710 | $46.2M |
| Goldman Sachs Group Inc. | 0.01% | Reduce -4.2% | 349,179 | $46.0M |
| Allspring Global Investments Holdings, LLC | 0.07% | Reduce -2.1% | 332,408 | $44.1M |
| Royal Bank of Canada | 0.01% | Add +6.8% | 332,300 | $43.8M |
| Clearbridge Investments, LLC | 0.04% | Reduce -0.0% | 310,035 | $40.8M |
| Rhumbline Advisers | 0.03% | Add +2.1% | 303,820 | $40.0M |
| Swiss National Bank | 0.02% | Add +7.7% | 292,600 | $38.5M |
| Rockefeller Capital Management L.P. | 0.07% | Add +0.3% | 282,097 | $37.2M |
| Candriam S.C.A. | 0.19% | Reduce -6.2% | 275,064 | $36.2M |
| Renaissance Group LLC | 1.36% | Reduce -2.3% | 246,377 | $32.5M |
| Barclays PLC | 0.01% | Reduce -3.3% | 243,984 | $32.1M |
| Principal Financial Group Inc. | 0.02% | Add +5.2% | 238,161 | $31.4M |
| Worldquant Millennium Advisors LLC | 0.12% | Add +169.6% | 237,904 | $31.3M |
| Sei Investments Co. | 0.03% | Add +31.1% | 235,251 | $31.0M |
| BNP Paribas Financial Markets | 0.02% | Add +9.1% | 233,500 | $30.8M |
| Wells Fargo & Company | 0.01% | Reduce -4.5% | 231,311 | $30.5M |
| Prudential Financial Inc. | 0.04% | Add +74.2% | 225,051 | $29.6M |
| California Public Employees Retirement System | 0.02% | Add +13.0% | 222,441 | $29.3M |
| Sumitomo Mitsui Trust Group, Inc. | 0.02% | Add +8.8% | 220,449 | $29.0M |
| Russell Investments Group, Ltd. | 0.03% | Add +76.1% | 219,755 | $28.9M |
| Envestnet Asset Management Inc. | 0.01% | Add +5.8% | 218,710 | $28.8M |
| PFM Health Sciences, LP | 3.04% | Add +32.2% | 215,678 | $28.4M |
| Defilade Capital Management, L.P. | 3.88% | New | 209,932 | $27.7M |
| Amundi | 0.01% | Add +22.4% | 203,637 | $26.8M |
| Nomura Asset Management International Inc. | 0.04% | Reduce -23.6% | 195,741 | $25.8M |
| Handelsbanken Fonder AB | 0.08% | Reduce -6.5% | 187,867 | $24.8M |
| Carmignac Gestion | 0.38% | Add +192.4% | 186,000 | $24.5M |
| HSBC Holdings PLC | 0.01% | Add +169.8% | 184,222 | $24.3M |
| Susquehanna Portfolio Strategies, LLC | 0.36% | No change | 184,035 | $24.2M |
| Trexquant Investment LP | 0.17% | Add +33.6% | 183,310 | $24.1M |
| Ensign Peak Advisors, Inc | 0.04% | Add +8.5% | 181,481 | $23.9M |
| VIRGINIA RETIREMENT SYSTEMS ET Al | 0.17% | Add +18.6% | 175,023 | $23.1M |
| New York State Common Retirement Fund | 0.03% | No change | 174,774 | $23.0M |
| Pacer Advisors, Inc. | 0.06% | Add +471.3% | 169,230 | $22.3M |
| Loomis Sayles & Co. L P | 0.03% | Reduce -2.1% | 165,735 | $21.8M |
| Mariner, LLC | 0.02% | Add +67.5% | 160,869 | $21.2M |
| FMR LLC | 0.00% | Add +119.8% | 154,867 | $20.4M |
| Connor, Clark & Lunn Investment Management Ltd. | 0.05% | Reduce -37.6% | 153,755 | $20.3M |
| Panagora Asset Management Inc. | 0.07% | New | 151,449 | $20.0M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -91.9% | 151,256 | $19.9M |
| Rock Springs Capital Management LP | 1.17% | Add +19.9% | 150,450 | $19.8M |
| American Century Companies Inc. | 0.01% | Reduce -5.2% | 150,298 | $19.8M |
| Integral Health Asset Management, LLC | 1.05% | No change | 150,000 | $19.8M |
| Capital Fund Management S.A. | 0.18% | Add +86.8% | 149,631 | $19.7M |
| Los Angeles Capital Management LLC | 0.08% | Reduce -88.5% | 149,111 | $19.6M |
| Andra AP-fonden | 0.23% | Add +118.3% | 148,191 | $19.5M |
| Bridgewater Associates | 0.09% | Reduce -1.2% | 148,141 | $19.5M |
| Cerity Partners LLC | 0.03% | Add +8.1% | 144,529 | $19.0M |
| DNB Asset Management AS | 0.07% | Add +1.3% | 141,232 | $18.6M |
"% of holder's portfolio" is NBIX's weight in each manager's 13F, not the share of Neurocrine Biosciences Inc. the manager owns.